Center for Cognitive Health

Hello Everyone! It's been a while since we've posted on here, but we're back!

For our first post back, we wanted to share a clinical trial that we are actively enrolling for. Attached is the poster for the study! The QR code at the bottom of the poster will take you to this link to sign up: https://trials.clinials.io/en-US/alzheimers

If you would like to view any more information about the drug being tested in this trial, it can be found through this link: https://actinogen.com.au/xanamem/

Please reach out to us with any questions or comments! If you are interested in joining this trial, you can call our office at 503-207-2066!

With Measure 109 going into effect this year, the potential benefits of psychedelic therapies, like psilocybin, are regularly making headlines. In our latest blog, we explore how psychedelic therapies may be beneficial to individuals experiencing neurodegenerative diseases, like Alzheimer’s, by promoting the activation of specific receptor sites and increasing neuronal growth factors. Click the link below to learn more!

Psychedelics May Help Treat Neurodegenerative Disorders – Center for Cognitive Health Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that affects millions of people worldwide. The hallmark features of AD include neuroinflammation, dendritic atrophy, and loss of synapse density in cortical regions controlling cognition, memory, and mood. Recent research has poi...